Cargando…

COVID-19 in Cancer Patients, Risk Factors for Disease and Adverse Outcome, a Population-Based Study From Norway

BACKGROUND: Cancer has been suggested as a risk factor for severe outcome of SARS-CoV-2 infection. In this population-based study we aimed to identify factors associated with higher risk of COVID-19 and adverse outcome. METHODS: Data on all confirmed SARS-CoV-2 positive patients in the period Januar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Johannesen, Tom Børge, Smeland, Sigbjørn, Aaserud, Stein, Buanes, Eirik Alnes, Skog, Anna, Ursin, Giske, Helland, Åslaug
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8027113/ https://www.ncbi.nlm.nih.gov/pubmed/33842366 http://dx.doi.org/10.3389/fonc.2021.652535

Ejemplares similares

Improvements in survival for patients with stage IV adenocarcinoma in the lung, diagnosed between 2010 – 2020 - A population-based registry study from Norway
por: Børø, Siri, et al.
Publicado: (2022)

Were cancer patients worse off than the general population during the COVID-19 pandemic? A population-based study from Norway, Denmark and Iceland during the pre-vaccination era
por: Johansson, Anna L.V., et al.
Publicado: (2023)

Menopausal hormone therapy and colorectal cancer: a linkage between nationwide registries in Norway
por: Botteri, Edoardo, et al.
Publicado: (2017)

Second International Symposium on the Molecular Biology of Breast Cancer, March 12-16, 2000, Lillehammer, Norway
por: Jones , Chris, et al.
Publicado: (2000)

National trends in incidence and survival of chronic lymphocytic leukemia in Norway for 1953–2012: a systematic analysis of population‐based data
por: Lenartova, Andrea, et al.
Publicado: (2016)

Clinical Epidemiology of Low-Grade and Dedifferentiated Osteosarcoma in Norway during 1975 and 2009
por: Berner, Kjetil, et al.
Publicado: (2015)

Targeting lung cancer through inhibition of checkpoint kinases
por: Syljuåsen, Randi G., et al.
Publicado: (2015)

Factors associated with failure to start consolidation durvalumab after definitive chemoradiation for locally advanced NSCLC
por: Langberg, Christian Wilhelm, et al.
Publicado: (2023)

Incidence of breast cancer subtypes in immigrant and non-immigrant women in Norway
por: Hjerkind, Kirsti V., et al.
Publicado: (2022)

A comparison of two registry-based systems for the surveillance of persons hospitalised with COVID-19 in Norway, February 2020 to May 2022
por: Whittaker, Robert, et al.
Publicado: (2023)

Metformin use and lung cancer survival: a population-based study in Norway
por: Brancher, Suzan, et al.
Publicado: (2020)

Cancer risk with folic acid supplements: a systematic review and meta-analysis
por: Wien, Tale Norbye, et al.
Publicado: (2012)

Acute kidney injury in patients with COVID-19 in the intensive care unit: evaluation of risk factors and mortality in a national cohort
por: Aukland, Eirik Aasen, et al.
Publicado: (2022)

A phase I/II escalation trial design T-RAD: Treatment of metastatic lung cancer with mRNA-engineered T cells expressing a T cell receptor targeting human telomerase reverse transcriptase (hTERT)
por: Maggadóttir, Sólrún Melkorka, et al.
Publicado: (2022)

Barriers to cervical cancer screening faced by immigrants: a registry-based study of 1.4 million women in Norway
por: Leinonen, Maarit K., et al.
Publicado: (2017)

Nordcan.R: a new tool for federated analysis and quality assurance of cancer registry data
por: Larønningen, Siri, et al.
Publicado: (2023)

Length of hospital stay and risk of intensive care admission and in-hospital death among COVID-19 patients in Norway: a register-based cohort study comparing patients fully vaccinated with an mRNA vaccine to unvaccinated patients
por: Whittaker, Robert, et al.
Publicado: (2022)

The impact of the COVID‐19 pandemic on cancer diagnosis based on pathology notifications: A comparison across the Nordic countries during 2020
por: Johansson, Anna L. V., et al.
Publicado: (2022)

No difference in risk of hospitalization between reported cases of the SARS-CoV-2 Delta variant and Alpha variant in Norway
por: Veneti, Lamprini, et al.
Publicado: (2022)

Radiotherapy-related lymphopenia in patients with advanced non-small cell lung cancer receiving palliative radiotherapy
por: Abravan, Azadeh, et al.
Publicado: (2020)

Gene expression profiles of breast biopsies from healthy women identify a group with claudin-low features
por: Haakensen, Vilde D, et al.
Publicado: (2011)

Age and product dependent vaccine effectiveness against SARS-CoV-2 infection and hospitalisation among adults in Norway: a national cohort study, July–November 2021
por: Starrfelt, Jostein, et al.
Publicado: (2022)

Quality assessment of the registration of vulvar and vaginal premalignant lesions at the Cancer Registry of Norway
por: Enerly, Espen, et al.
Publicado: (2012)

Lung Function After Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer, Changes and Predictive Markers
por: Berg, Janna, et al.
Publicado: (2021)

Mammographic screening debate on study design: a need to move the field forward
por: Ursin, Giske
Publicado: (2012)

Serum estradiol levels associated with specific gene expression patterns in normal breast tissue and in breast carcinomas
por: Haakensen, Vilde D, et al.
Publicado: (2011)

Improving public cancer care by implementing precision medicine in Norway: IMPRESS-Norway
por: Helland, Åslaug, et al.
Publicado: (2022)

Late Adverse Health Outcomes and Quality of Life after curative radiotherapy + long-term ADT in Prostate Cancer Survivors: Comparison with men from the general population
por: Fosså, Sophie D., et al.
Publicado: (2022)

Protein Kinase C Isozymes Associated With Relapse Free Survival in Non-Small Cell Lung Cancer Patients
por: Halvorsen, Ann Rita, et al.
Publicado: (2020)

Correction to: Improving public cancer care by implementing precision medicine in Norway: IMPRESS-Norway
por: Helland, Åslaug, et al.
Publicado: (2022)

Identification of potential carcinogenic and chemopreventive effects of prescription drugs: a protocol for a Norwegian registry-based study
por: Andreassen, Bettina Kulle, et al.
Publicado: (2019)

Prognostic Significance of the Loss of Heterozygosity of KRAS in Early-Stage Lung Adenocarcinoma
por: Khadse, Anand, et al.
Publicado: (2022)

Clinical epidemiology and treatment outcomes of spindle cell non-osteogenic bone sarcomas – A nationwide population-based study
por: Berner, Kjetil, et al.
Publicado: (2018)

Trajectories of hospitalisation for patients infected with SARS-CoV-2 variant B.1.1.7 in Norway, December 2020 – April 2021
por: Whittaker, Robert, et al.
Publicado: (2021)

The use of public transport and contraction of SARS-CoV-2 in a large prospective cohort in Norway
por: Ellingjord-Dale, Merete, et al.
Publicado: (2022)

Treatment approach and survival from glioblastoma: results from a population-based retrospective cohort study from Western Norway
por: Bjorland, Line Sagerup, et al.
Publicado: (2021)

Trajectories of body mass index in adulthood and risk of subtypes of postmenopausal breast cancer
por: Busund, Marit, et al.
Publicado: (2023)

The COVID-19 pandemic in Norway: The dominance of social implications in framing the policy response
por: Ursin, Gøril, et al.
Publicado: (2020)

Nature visits during the COVID-19 pandemic in Norway: Facilitators, motives, and associations with sociodemographic characteristics
por: Litleskare, Sigbjørn, et al.
Publicado: (2023)

Mental Health Staff Perspectives on Spiritual Care Competencies in Norway: A Pilot Study
por: Cone, Pamela, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ghjtbg7c5nvk41ch296lfb33ea